SSSumathi Sankaran-Walters

Sumathi Sankaran-Walters

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sumathi Sankaran-Walters has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Irina Grishina

    Department of Medical Microbiology and Immunology, University of CA Davis, USA

    4 shared publications
  • Anne Fenton

    Department of Medical Microbiology and Immunology, University of CA, Davis, One Shields Ave, Davis, CA 95616, USA

    3 shared publications
  • Satya Dandekar

    Department of Medical Microbiology and Immunology, University of CA Davis, USA

    3 shared publications
  • Thomas Prindiville

    Department of Internal Medicine, University of CA Davis, Sacramento, USA

    3 shared publications
  • Anne Thai

    Department of Internal Medicine, University of CA Davis, Sacramento, USA

    2 shared publications
  • Jay Li

    Department of Medical Microbiology and Immunology, University of CA Davis, USA

    2 shared publications

Latest Publications

  • Open Access

    Gender Differences, Aging and Hormonal Status in Mucosal Injury and Repair

    by Irina Grishina, Anne Fenton, Sumathi Sankaran-Walters

    As the "baby boomers" age, the percentage of the population over sixty-five years of age is increasing rapidly. Chronic disease management is an important component in the care of the elderly. The effects of aging on different organ systems are also pertinent; such as the weakening homeostatic response to injury in the older individuals. Mucosal surfaces have the largest combined surface area in the body and are the site of important host microbe interactions, especially in the gut which is prone to injury, both from local and systemic insult. This susceptibility has been known to increase with age. Therefore it is important to understand the interplay between aging, injury and recovery at the mucosal surface. Sex hormones play an important role in the maintenance of the mucosal barrier function as well as the mucosa associated immune function in both genders. Menopause in women is a defined time period in which major hormonal changes occur such as a decline in systemic estradiol levels. The differential levels of sex hormones contribute to the sexual dimorphism seen in response to injury at the mucosal surface, prior to and following menopause. Thus the effect of sex hormone and aging on mucosal mechanisms in response to injury is an important area of investigation.


  • Open Access

    Analysis of Gut Microbiome and Diet Modification in Patients with Crohn’s Disease

    by Sumathi Sankaran Walters, Antonio Quiros, Matthew Rolston, Irina Grishina, Jay Li, Anne Fenton, Todd Z. DeSantis, Anne Thai, Gary L Andersen, Peggy Papathakis, et al.

    The human intestine harbors trillions of commensal microbes that live in homeostasis with the host immune system


  • Open Access

    Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease

    by Angela Sena, Irina Grishina, Anne Thai, Larissa Goulart, Monica Macal, Anne Fenton, Jay Li, Thomas Prindiville, Sonia Maria Oliani, Satya Dandekar, et al.

    Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic factors with the host immune system. Mechanisms contributing to immune dysregulation in IBD are not fully defined. Development of novel therapeutic strategies is focused on controlling aberrant immune response in IBD. Current IBD therapy utilizes a combination of immunomodulators and biologics to suppress pro-inflammatory effectors of IBD. However, the role of immunomodulatory factors such as annexin A1 (ANXA1) is not well understood. The goal of this study was to examine the association between ANXA1 and IBD, and the effects of anti-TNF-α, Infliximab (IFX), therapy on ANXA1 expression. ANXA1 and TNF-α transcript levels in PBMC were measured by RT PCR. Clinical follow up included the administration of serial ibdQs. ANXA1 expression in the gut mucosa was measured by IHC. Plasma ANXA1 levels were measured by ELISA. We found that the reduction in ANXA1 protein levels in plasma coincided with a decrease in the ANXA1 mRNA expression in peripheral blood of IBD patients. ANXA1 expression is upregulated during IFX therapy in patients with a successful intervention but not in clinical non-responders. The IFX therapy also modified the cellular immune activation in the peripheral blood of IBD patients. Decreased expression of ANXA1 was detected in the colonic mucosa of IBD patients with incomplete resolution of inflammation during continuous therapy, which correlated with increased levels of TNF-α transcripts. Gut mucosal epithelial barrier disruption was evident by increased plasma bacterial 16S levels. Loss of ANXA1 expression may support inflammation during IBD and can serve as a biomarker of disease progression. Changes in ANXA1 levels may be predictive of therapeutic efficacy.


  • Open Access

    Sex differences matter in the gut: effect on mucosal immune activation and inflammation

    by Sumathi Sankaran-Walters, Monica Macal, Irina Grishina, Lauren Nagy, Larissa Goulart, Kathryn Coolidge, Jay Li, Anne Fenton, Theodore Williams, Mary K Miller, et al.

    Women and men have diverse responses to many infectious diseases. These differences are amplified following menopause. However, despite extensive information regarding the effects of sex hormones on immune cells, our knowledge is limited regarding the effects of sex and gender on the function of the mucosal immune system. Sex differences also manifest in the prevalence of gut associated inflammatory and autoimmune disorders, including Crohn’s disease, ulcerative colitis and Celiac disease. It is thus hypothesized that a baseline sex-associated difference in immune activation may predispose women to inflammation-associated disease.


  • Epstein–Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease

    by Sumathi Sankaran-Walters, Kanat Ransibrahmanakul, Irina Grishina, Jason Hung, Enrique Martinez, Thomas Prindiville, Satya Dandekar